Rapid Micro Biosystems, Inc.
RPID · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $149 | $154 | $116 | $39 |
| - Cash | $19 | $18 | $19 | $17 |
| + Debt | $24 | $6 | $6 | $6 |
| Enterprise Value | $154 | $141 | $103 | $29 |
| Revenue | $8 | $7 | $7 | $8 |
| % Growth | 7.9% | 0.8% | -12.3% | – |
| Gross Profit | $2 | $2 | $0 | $1 |
| % Margin | 29% | 26.8% | 5.6% | 11.9% |
| EBITDA | -$10 | -$11 | -$11 | -$9 |
| % Margin | -131.1% | -152% | -150.1% | -113.9% |
| Net Income | -$12 | -$12 | -$11 | -$10 |
| % Margin | -146.8% | -163.3% | -156.3% | -117.6% |
| EPS Diluted | -0.25 | -0.27 | -0.26 | -0.22 |
| % Growth | 7.4% | -3.8% | -18.2% | – |
| Operating Cash Flow | -$9 | -$10 | -$9 | -$10 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$9 | -$10 | -$9 | -$10 |